Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2026-07-01 16:34:14 ET · period of report 2026-06-29 · accession 0001762507-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-01 16:34 | 2026-06-29 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | S - Sale | $1.11 | -56.0K | 616.6K | -8% | -$62.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | S | D | 56,019 | $1.11 | 616,616 | D | — | — | (F1) This sale represents an automatic "sell to cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units granted on June 28, 2024. The sale was effected pursuant to durable automatic sell-to-cover instructions adopted by the reporting person on September 8, 2025. |